“Some of the growth sectors one has to avoid because one does not know when the Fed is going to pivot and after this morning’s report it does not look like they are going to pivot anytime soon. What they have been saying is that they are going to keep rates higher for a long period of time which means one has to stick more defensive and value rather than cyclical and growth.”

A total of 158 shares changed hands on the counter till 11:01AM (IST).

The Relative Strength Index of the stock stood at 57.71 on Wednesday.

The stock quoted a 52-week high price of Rs 1081.0 and a 52-week low of Rs 697.05.

A total of 13,220 shares changed hands on the counter till 01:14PM (IST).

The region extended Tuesday's losses, with London's benchmark FTSE 100 index tumbling 1.6 percent to 6,870.45 points.In the eurozone, Frankfurt's DAX index dived 1.3 percent to 11,978.14 points and the Paris CAC 40 shed 1.4 percent to 5,672.99.

The Relative Strength Index of the stock stood at 29.69 on Wednesday.

For the quarter ended June 30, 2022, the company has reported a consolidated total income of Rs 1567.30 crore, up 10.75 per cent from last quarter total income of Rs 1415.20 crore and up 28.31 per cent from last year same quarter total income of Rs 1221.50 crore.

The domestic pharmaceutical player announced its acquisition of Curatio Healthcare for Rs 2,000 crore to strengthen its presence in the dermatology segment. It has entered into a definitive agreement to acquire 100 per cent stake, the company said in an exchange filing.